AI-assisted, human-published
02/20/2026 /Funding Events
Altesa BioSciences Secures $75M in Series B Funding to Advance Treatment for Chronic Lung Diseases
Altesa BioSciences, a clinical-stage pharmaceutical company, has secured a $75 million Series B funding round oversubscribed by Forbion and joined by Sanofi and existing investors.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com